Wolfgang Marguerre is a German businessman, the self-made billionaire Founder and Executive Chairman of Octapharma AG, a major global manufacturer of human protein and plasma-derived therapies. His career is rooted in pharmaceuticals, medical technology, and entrepreneurial audacity.

Marguerre holds a B.A. in Economics from Ludwig Maximilian University of Munich (LMU). His philosophical approach centers on scale, technological excellence, and long-term commitment to private ownership (rejecting public listing to focus on R&D). He founded Octapharma in 1983 in Lachen, Switzerland, recognizing the immense, untapped global demand for safe, high-quality plasma protein therapies.

• Octapharma AG (Founder & Chairman): The core private asset, a major global manufacturer of plasma-derived therapies (specializing in immunology and critical care).
• Pharmaceutical Pioneer: His success is built on scale manufacturing and vertical integration (controlling the entire plasma collection and fractionation process) and dominating the market for essential plasma therapies.
• Investment Strategy: His philosophy is rooted in long-term investment in industrial assets and R&D and leveraging the massive global growth of specialized biological drugs.
• Family Governance: The company remains 100 percent privately owned and controlled by the family.

Wolfgang Marguerre's strategic genius was his commitment to vertical integration and safety. He founded Octapharma in 1983, successfully building it into a global force by pioneering the scale collection and processing of human plasma to manufacture life-saving therapies. His structural contribution is immense: pioneering the modern, scale plasma therapeutics model and providing essential treatments for rare and chronic diseases globally. His commitment to private ownership allows for massive, sustained R&D investment.

He remains Executive Chairman, guiding the company's continuous expansion and technological modernization. His wealth is secured by the colossal, long-term, stable profitability of the global pharmaceutical and medical technology sector.

Wolfgang Marguerre's social impact stems from Octapharma's role in providing essential, life-saving plasma-derived therapies for rare and chronic diseases globally, contributing significantly to public health. His personal philanthropy supports various medical research and educational initiatives, often focused on blood diseases and clinical advancements.

His personal philanthropy supports various community and educational initiatives.

Wolfgang Marguerre maintains the professional, composed style of a corporate executive. His attire is consistently formal and high-quality, favoring tailored suits. His aesthetic reflects serious authority and stability, typical of a leader in the global medical technology sector.

Residing in Switzerland, his luxury is the immense security and financial reward derived from his multi-billion dollar fortune. His life is dedicated to corporate governance, strategic investment, and industrial scale.